(Circulation. 1999;99:1290-1294.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Klinik für Gastroenterologie, Hepatologie, und Infektiologie (C.M., M.A., H.J., M.M., B.S., D.H.); the Institut für Medizinische Mikrobiologie und Virologie (O.A.); and the Klinik für Kardiologie, Pneumologie, und Angiologie (U.H., B.E.S., M.P.H.), Heinrich-Heine-Universität, Düsseldorf, Germany. Dr Manegold is now at the Bernhard-Nocht-Institut für Tropenmedizin, Hamburg, Germany.
Correspondence to Dr Christoph Manegold, Bernhard-Nocht-Institut für Tropenmedizin, Klinische Abteilung, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany. E-mail manegold{at}bni.uni-hamburg.de
BackgroundRestenosis is a common problem after all revascularization procedures in atherosclerotic coronary arteries. Reactivated human cytomegalovirus (CMV) has been detected in tissues of restenotic vascular lesions and was hypothesized to be a contributing pathogenic factor. Recent data suggest an association of restenosis after optimal coronary atherectomy with CMV serostatus, and a possible role of antiviral therapy was discussed. We therefore tested the hypothesis that prior CMV infection might be a risk factor for restenosis after conventional coronary balloon angioplasty (PTCA).
Methods and ResultsWe analyzed 92 consecutive patients who had been admitted for control angiography after previous PTCA within a mean interval of 6 months. Anti-CMV antibodies were measured as an indicator of prior CMV infection and latency. The coronary angiograms before PTCA, directly after, and 6 months later were analyzed quantitatively. Sixty-five percent of the patients were CMV-positive. Before PTCA, the degree (mean±SD) of stenosis was 69±10% in CMV-positive and 68±8.3% in CMV-negative subjects. PTCA resulted in a residual stenosis of 39% in both groups. After 6 months, the late losses of luminal diameter in the CMV-positive and -negative groups were 11±13% and 12±15%, respectively (P=0.658). In an ANCOVA with 25 potential risk factors for restenosis, CMV serostatus was not significantly associated with restenosis development.
ConclusionsOur data indicate that prior CMV infection, in contrast to optimal atherectomy, is not associated with chronic restenosis after conventional coronary balloon angioplasty. The results do not support a possible benefit from antiviral therapy.
Key Words: restenosis viruses angioplasty atherosclerosis angiography
This article has been cited by other articles:
![]() |
Y. H. Shen, L. Zhang, B. Utama, J. Wang, Y. Gan, X. Wang, J. Wang, L. Chen, G. M. Vercellotti, J. S. Coselli, et al. Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10) Cardiovasc Res, February 1, 2006; 69(2): 502 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Toutouzas, A. Colombo, and C. Stefanadis Inflammation and restenosis after percutaneous coronary interventions Eur. Heart J., October 1, 2004; 25(19): 1679 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.H. Shen, B. Utama, J. Wang, M. Raveendran, D. Senthil, W.J. Waldman, J.D. Belcher, G. Vercellotti, D. Martin, B.M. Mitchelle, et al. Human Cytomegalovirus Causes Endothelial Injury Through the Ataxia Telangiectasia Mutant and p53 DNA Damage Signaling Pathways Circ. Res., May 28, 2004; 94(10): 1310 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF] |
||||
![]() |
F.-J. Neumann, A. Kastrati, T. Miethke, J. Mehilli, G. Pogatsa-Murray, W. Koch, M. Seyfarth, and A. Schomig Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement Circulation, September 4, 2001; 104(10): 1135 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Schiele, M K Batur, M F Seronde, N Meneveau, P Sewoke, A Bassignot, G Couetdic, F Caulfield, and J-P Bassand Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study Heart, March 1, 2001; 85(3): 304 - 311. [Abstract] [Full Text] |
||||
![]() |
C. Espinola-Klein, H.-J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, G. Hafner, U. Pfeifer, and J. Meyer Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? Stroke, September 1, 2000; 31(9): 2127 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Moreno and I. F. Palacios Cytomegalovirus and Restenosis After Percutaneous Transluminal Coronary Angioplasty Circulation, April 11, 2000; 101 (14): e163 - e163. [Full Text] [PDF] |
||||
![]() |
C. Bartels, M. Maass, G. Bein, N. Brill, J. F. M. Bechtel, R. Leyh, and H.-H. Sievers Association of Serology With the Endovascular Presence of Chlamydia pneumoniae and Cytomegalovirus in Coronary Artery and Vein Graft Disease Circulation, January 18, 2000; 101(2): 137 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Bertrand and C. Bauters Cytomegalovirus Infection and Coronary Restenosis Circulation, March 16, 1999; 99(10): 1278 - 1279. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |